CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$20,854,480
+9.5%
179,780
+10.9%
0.01%
+20.0%
Q2 2023$19,038,288
+48.7%
162,166
+1.4%
0.01%
+25.0%
Q1 2023$12,800,713
+0.6%
159,889
-0.5%
0.00%0.0%
Q4 2022$12,723,920
+16.8%
160,615
+2.8%
0.00%0.0%
Q3 2022$10,893,000
+11.5%
156,271
+5.1%
0.00%
+33.3%
Q2 2022$9,768,000
-1.1%
148,752
+0.3%
0.00%0.0%
Q1 2022$9,872,000
+1.1%
148,347
+6.3%
0.00%0.0%
Q4 2021$9,767,000
+49.2%
139,618
+11.4%
0.00%
+50.0%
Q3 2021$6,547,000
-21.1%
125,384
+2.7%
0.00%
-33.3%
Q2 2021$8,301,000
-5.9%
122,072
+6.6%
0.00%0.0%
Q1 2021$8,822,000
+48.2%
114,505
+15.5%
0.00%
+50.0%
Q4 2020$5,951,000
+42.9%
99,179
+2.6%
0.00%0.0%
Q3 2020$4,163,000
+31.3%
96,696
+26.3%
0.00%0.0%
Q2 2020$3,171,000
+6.4%
76,548
+11.1%
0.00%0.0%
Q1 2020$2,980,000
-20.1%
68,903
+2.3%
0.00%0.0%
Q4 2019$3,731,000
+62.7%
67,364
+2.0%
0.00%
+100.0%
Q3 2019$2,293,000
+173.0%
66,028
+216.8%
0.00%0.0%
Q2 2019$840,00020,8390.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders